124
Views
0
CrossRef citations to date
0
Altmetric
COMMENTARIES

Commentary on ‘‘Should the diagnostic boundaries of schizophrenia be expanded?’’

, , &
Pages 107-112 | Published online: 03 Mar 2011
 

Acknowledgements

The authors were supported by a National Health and Medical Research Council (NHMRC) Program Grant (ID: 566529). ARY was supported by a NHMRC Senior Research Fellowship (ID: 566593). CP was supported by a NHMRC Senior Principal Research Fellowship (ID: 628386).

In the last 5 years, ARY has received Honoraria from Eli Lilly, Bristol Myer Squibb, and Janssen-Cilag. PDM has received Honoraria from Eli Lilly, Janssen-Cilag, Pfizer, and Astra Zeneca. ARY and PDM are investigators on an Investigator Initiated study of the at risk group funded by Astra Zeneca. CP has received grant support from Janssen-Cilag, Eli Lilly, Hospira (Mayne), and Astra Zeneca, and has provided consultancy to Janssen-Cilag, Eli Lilly, Hospira (Mayne), Astra Zeneca, Pfizer, Schering Plough, and is an investigator on an Investigator Initiated study of bipolar disorder funded by Astra Zeneca. SJW has no disclosures.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 267.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.